美股A股
StockGist
Back
10-Q2026-05-13· grok-4-1-fast-non-reasoning

ALT · Altimmune, Inc.

0001326190-26-000040

SEC filing

Summary

Revenue was $5.0K (0.0%) Operating Income was -$24.2M (-11.1%) Net Income was -$22.6M (-15.3%) Eps was $-0.18 (30.8%)

Key takeaways